Comment from Wise Audrey
AnonymousSupportIndividual
Summary: Audrey Wise, a patient who uses compounded peptides for migraines, supports the action to ensure these substances remain available through legitimate 503A pharmacies. She expresses concern that removing them from the list would force patients toward unregulated markets and requests a focus on domestic manufacturing.
I have been using a compounded peptide for over one year. I get it from a 503 a pharmacy and I'm very comfortable knowing they triple test and triple filter everything.
My fear is if these are pulled, I don't want to have to go to a grey/black market to get my peptide. It has eliminated my migraines and have improved my health overall.
Please consider sourcing everything in the United States from manufacturing to the pharmacies. Getting out of country products is very concerning.
Thank you for your consideration,
Audrey Wise